Quantcast
Last updated on April 16, 2014 at 17:33 EDT

Latest Clinical research Stories

2014-04-15 12:30:09

PITTSBURGH, April 15, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that it and its partner Famy Care Ltd. have entered into a settlement and license agreement with Warner Chilcott Company, LLC, settling the parties' litigation in connection with Mylan's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Norethindrone and Ethinyl Estradiol Chewable Tablets 0.8 mg/0.025 mg and Ferrous Fumarate Chewable Tablets. This...

2014-04-15 08:30:06

Purchase adds global regulatory writing and submission services to Certara's drug development consulting expertise NEW YORK, April 15, 2014 /PRNewswire/ -- Arsenal Capital Partners, a leading New York based private equity firm that invests in middle market healthcare, specialty industrial, and financial services companies, announced today the acquisition of Synchrogenix, the leading regulatory writing and related services firm. Synchrogenix provides services to pharmaceutical,...

2014-04-15 08:29:42

DUBLIN, April 15, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Mylan Inc. and Famy Care Ltd. to settle all outstanding patent litigation related to Mylan's generic version of Generess(®) FE (norethindrone, ethinyl estradiol and ferrous fumarate chewable tablets). Under the terms of the agreement, Actavis will grant Mylan a license to market its generic version of Generess(®) FE under its pending Abbreviated New Drug...

2014-04-15 08:29:25

Dr. Steve Yang Joins Company as EVP and Chief Operating Officer; Edward Hu Named Chief Investment Officer and Remains Chief Financial Officer SHANGHAI, April 15, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that Dr. Steve Yang has joined the company as Executive Vice President and Chief Operating Officer. Edward Hu will...

2014-04-14 23:10:18

On April 11, the FDA advised consumers not to purchase or use Lite Fit USA as it was confirmed it contained sibutramine. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) April 14, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for medical products including weight loss products. As the...

2014-04-14 23:02:32

As drug and devicemakers well know, the convention floor is a great place to get new customers and make new sales. In the time it takes to hold a staff meeting or have a business lunch, learn how to implement a four-step audit process that teaches how to audit operations before the FDA or an international regulatory body catches a misstep. Falls Church (PRWEB) April 14, 2014 How to Train Your Staff to Spot Promotional Violations **FDAnews Webinar** April 24, 2014 — 1:30 p.m. – 3:00...

2014-04-11 23:22:36

The FDA warned consumers on April 8, to immediately stop using Zi Xiu Tang Bee Pollen capsules by Guangzhou Zi Xiu Tang Biotechnology Co. Ltd, because there were found to contain undeclared drug ingredients. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) April 11, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from...

2014-04-11 23:01:51

Transparency Market Research Report Added "Biosimilar And Follow-On Biologics Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018" to its database. Browse Full Report - http://www.transparencymarketresearch.com/biosimilar-and-follow-on-biologics-market.html. Albany, New York, USA (PRWEB) April 11, 2014 There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new...

2014-04-11 08:24:12

ALBANY, New York, April 11, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Clinical Trial Management System Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019," the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Browse Global...

2014-04-10 23:30:01

Verified Clinical Trials and ACRES form a strategic alliance to further the innovative systems-based solutions necessary to promote and facilitate research subject safety and improve data quality across the clinical trials industry. Verified Clinical Trials has pledged use of the research subject clinical trials database registry to stop dual enrollment in clinical trials to ACRES research sites. Cambridge, MA and Garden City, New York April 9, 2014 (PRWEB) April 10, 2014 Verified...